This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SYB | changed offer terms | 08/02/08 | 3 | 1.1K | |||
|
|||||||
SYB | interesting read at business spectator | 08/02/08 | 0 | 365 | |||
|
|||||||
SYB | how easily can they offer less qm | 29/01/08 | 2 | 641 | |||
|
|||||||
SYB | offer extended again | 24/01/08 | 0 | 354 | |||
|
|||||||
SYB | syb sux | 07/01/08 | 2 | 659 | |||
|
|||||||
SYB | symbion what now | 20/12/07 | 0 | 423 | |||
|
|||||||
SYB | syb what now | 02/12/07 | 5 | 1.0K | |||
|
|||||||
SYB | dear mr bateman | 23/11/07 | 5 | 1.0K | |||
|
See All Discussions